Celcuity gains FDA approval for closely watched breast cancer drug
Celcuity gains FDA approval for the closely watched breast cancer drug Revtorpyk (gedatolisib).
Celcuity
Private
PI3K/mTOR therapies, Companion Diagnostics
Company Info
Recent News
Celcuity wins breast cancer nod, securing ‘differentiated foothold’ in market
Celcuity wins breast cancer nod, securing ‘differentiated foothold’ in market
Celcuity set to be Big Pharma 'strategic target' after approval
Celcuity set to be Big Pharma 'strategic target' after approval
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer